Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1326 | 2716 | 36.7 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
1326 | 1 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//LOW DOSE ASPIRIN | 2716 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NSAIDS | authKW | 359326 | 12% | 10% | 334 |
2 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | authKW | 340953 | 11% | 10% | 304 |
3 | LOW DOSE ASPIRIN | authKW | 272962 | 3% | 35% | 69 |
4 | COX 2 SELECTIVE INHIBITORS | authKW | 120880 | 1% | 49% | 22 |
5 | GASTROPROTECTIVE AGENTS | authKW | 115618 | 0% | 86% | 12 |
6 | PEPTIC ULCER | authKW | 110953 | 4% | 9% | 111 |
7 | COX 2 INHIBITORS | authKW | 108419 | 3% | 12% | 78 |
8 | ROFECOXIB | authKW | 95805 | 2% | 14% | 59 |
9 | COX 2 SPECIFIC INHIBITORS | authKW | 79143 | 0% | 54% | 13 |
10 | COXIBS | authKW | 71005 | 1% | 18% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 34576 | 34% | 0% | 930 |
2 | Rheumatology | 19819 | 16% | 0% | 426 |
3 | Medicine, General & Internal | 5401 | 22% | 0% | 585 |
4 | Pharmacology & Pharmacy | 4964 | 26% | 0% | 718 |
5 | Health Care Sciences & Services | 548 | 3% | 0% | 94 |
6 | Health Policy & Services | 276 | 2% | 0% | 52 |
7 | Primary Health Care | 203 | 1% | 0% | 26 |
8 | Geriatrics & Gerontology | 119 | 1% | 0% | 38 |
9 | Public, Environmental & Occupational Health | 97 | 4% | 0% | 106 |
10 | Medicine, Research & Experimental | 69 | 3% | 0% | 85 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | OFF CLIN TRAINING | 42310 | 0% | 47% | 8 |
2 | POST GEN PRACTITIONERS FORMAT | 22482 | 0% | 100% | 2 |
3 | POST MKT SURVEILLANCE PROGRAM | 22482 | 0% | 100% | 2 |
4 | REDCAR CLEVELAND PRIMARY CARE TRUST | 22482 | 0% | 100% | 2 |
5 | SERV DIGEST DIS | 20567 | 1% | 13% | 14 |
6 | GASTROENTEROL | 16669 | 13% | 0% | 340 |
7 | MUNICIPAL HLTH RISK ANAL | 14987 | 0% | 67% | 2 |
8 | PATIENT HLTH | 14987 | 0% | 67% | 2 |
9 | UNITE STAT PL | 14987 | 0% | 67% | 2 |
10 | SECT DIGEST LIVER DIS | 13780 | 0% | 14% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 63127 | 7% | 3% | 190 |
2 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 9783 | 2% | 2% | 45 |
3 | ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 7378 | 1% | 3% | 25 |
4 | JOURNAL OF RHEUMATOLOGY | 6714 | 3% | 1% | 88 |
5 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 6387 | 3% | 1% | 75 |
6 | AMERICAN JOURNAL OF GASTROENTEROLOGY | 5408 | 3% | 1% | 75 |
7 | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 3856 | 1% | 1% | 32 |
8 | RHEUMATOLOGY | 3772 | 1% | 1% | 40 |
9 | CURRENT MEDICAL RESEARCH AND OPINION | 3394 | 1% | 1% | 37 |
10 | ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 3309 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NSAIDS | 359326 | 12% | 10% | 334 | Search NSAIDS | Search NSAIDS |
2 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | 340953 | 11% | 10% | 304 | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS |
3 | LOW DOSE ASPIRIN | 272962 | 3% | 35% | 69 | Search LOW+DOSE+ASPIRIN | Search LOW+DOSE+ASPIRIN |
4 | COX 2 SELECTIVE INHIBITORS | 120880 | 1% | 49% | 22 | Search COX+2+SELECTIVE+INHIBITORS | Search COX+2+SELECTIVE+INHIBITORS |
5 | GASTROPROTECTIVE AGENTS | 115618 | 0% | 86% | 12 | Search GASTROPROTECTIVE+AGENTS | Search GASTROPROTECTIVE+AGENTS |
6 | PEPTIC ULCER | 110953 | 4% | 9% | 111 | Search PEPTIC+ULCER | Search PEPTIC+ULCER |
7 | COX 2 INHIBITORS | 108419 | 3% | 12% | 78 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
8 | ROFECOXIB | 95805 | 2% | 14% | 59 | Search ROFECOXIB | Search ROFECOXIB |
9 | COX 2 SPECIFIC INHIBITORS | 79143 | 0% | 54% | 13 | Search COX+2+SPECIFIC+INHIBITORS | Search COX+2+SPECIFIC+INHIBITORS |
10 | COXIBS | 71005 | 1% | 18% | 36 | Search COXIBS | Search COXIBS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LANZA, FL , CHAN, FKL , QUIGLEY, EMM , (2009) GUIDELINES FOR PREVENTION OF NSAID-RELATED ULCER COMPLICATIONS.AMERICAN JOURNAL OF GASTROENTEROLOGY. VOL. 104. ISSUE 3. P. 728 -738 | 79 | 84% | 232 |
2 | LAZZARONI, M , PORRO, GB , (2009) MANAGEMENT OF NSAID-INDUCED GASTROINTESTINAL TOXICITY FOCUS ON PROTON PUMP INHIBITORS.DRUGS. VOL. 69. ISSUE 1. P. 51 -69 | 86 | 80% | 28 |
3 | CASTELLSAGUE, J , RIERA-GUARDIA, N , CALINGAERT, B , VARAS-LORENZO, C , FOURRIER-REGLAT, A , NICOTRA, F , STURKENBOOM, M , PEREZ-GUTTHANN, S , (2012) INDIVIDUAL NSAIDS AND UPPER GASTROINTESTINAL COMPLICATIONS A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES (THE SOS PROJECT).DRUG SAFETY. VOL. 35. ISSUE 12. P. 1127 -1146 | 57 | 84% | 72 |
4 | BROWN, TJ , HOOPER, L , ELLIOTT, RA , PAYNE, K , WEBB, R , ROBERTS, C , ROSTOM, A , SYMMONS, D , (2006) A COMPARISON OF THE COST-EFFECTIVENESS OF FIVE STRATEGIES FOR THE PREVENTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED GASTROINTESTINAL TOXICITY: A SYSTEMATIC REVIEW WITH ECONOMIC MODELLING.HEALTH TECHNOLOGY ASSESSMENT. VOL. 10. ISSUE 38. P. 1 -+ | 102 | 62% | 55 |
5 | SCARPIGNATO, C , LANAS, A , BLANDIZZI, C , LEMS, WF , HERMANN, M , HUNT, RH , (2015) SAFE PRESCRIBING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH OSTEOARTHRITIS - AN EXPERT CONSENSUS ADDRESSING BENEFITS AS WELL AS GASTROINTESTINAL AND CARDIOVASCULAR RISKS.BMC MEDICINE. VOL. 13. ISSUE . P. - | 92 | 45% | 20 |
6 | ARORA, G , SINGH, G , TRIADAFILOPOULOS, G , (2009) PROTON PUMP INHIBITORS FOR GASTRODUODENAL DAMAGE RELATED TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS OR ASPIRIN: TWELVE IMPORTANT QUESTIONS FOR CLINICAL PRACTICE.CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. VOL. 7. ISSUE 7. P. 725-735 | 74 | 82% | 11 |
7 | LAINE, L , (2001) APPROACHES TO NONSTEROIDAL ANTI-INFLAMMATORY DRUG USE IN THE HIGH-RISK PATIENT.GASTROENTEROLOGY. VOL. 120. ISSUE 3. P. 594 -606 | 62 | 90% | 283 |
8 | LAZZARONI, M , PORRO, GB , (2001) PROPHYLAXIS AND TREATMENT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED UPPER GASTROINTESTINAL SIDE-EFFECTS.DIGESTIVE AND LIVER DISEASE. VOL. 33. ISSUE . P. S44 -S58 | 86 | 88% | 12 |
9 | WOLFE, MM , LICHTENSTEIN, DR , SINGH, G , (1999) GASTROINTESTINAL TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 340. ISSUE 24. P. 1888 -1899 | 55 | 63% | 1207 |
10 | MERLE, V , THIEFIN, G , CZERNICHOW, P , (2004) EPIDEMIOLOGY OF GASTRODUODENAL COMPLICATIONS ASSOCIATED WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUG USE.GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. VOL. 28. ISSUE . P. C27 -C36 | 71 | 92% | 3 |
Classes with closest relation at Level 1 |